XPhyto Epilepsy clinical trial planned in 2022 with its proprietary fast-dissolving CBD oral strips
Dec 15, 2021
Vancouver, Canada, and Uttenweiler, Germany (December 15, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide...